Esophageal Cancer: CT, Endoscopic US, and FDG PET for Assessment of Response to Neoadjuvant Therapy—Systematic Review1
…, JTM Plukker, JJB Van Lanschot, GW Sloof - Radiology, 2005 - pubs.rsna.org
PURPOSE: To compare diagnostic accuracy of computed tomography (CT), endoscopic
ultrasonography (US), and fluorine 18 fluorodeoxyglucose (FDG) positron emission tomography …
ultrasonography (US), and fluorine 18 fluorodeoxyglucose (FDG) positron emission tomography …
Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable …
…, J Pruim, H van Dekken, JJ Bergman, GW Sloof… - Annals of …, 2011 - journals.lww.com
Background: Neoadjuvant chemoradiotherapy before surgery can improve survival in
patients with potentially curable esophageal cancer, but not all patients respond. …
patients with potentially curable esophageal cancer, but not all patients respond. …
Synchronous primary neoplasms detected on 18F-FDG PET in staging of patients with esophageal cancer
…, PL Jager, HM van Dullemen, GW Sloof… - Journal of nuclear …, 2005 - Soc Nuclear Med
Because of improvements in diagnostic technology, the incidental detection of synchronous
primary tumors during the preoperative work-up of patients with esophageal cancer has …
primary tumors during the preoperative work-up of patients with esophageal cancer has …
[HTML][HTML] Value of EUS in determining curative resectability in reference to CT and FDG-PET: the optimal sequence in preoperative staging of esophageal cancer?
…, MI van Berge Henegouwen, GW Sloof… - Annals of surgical …, 2016 - Springer
Background The separate value of endoscopic ultrasonography (EUS), multidetector
computed tomography (CT), and 18 F-fluorodeoxyglucose positron emission tomography (FDG-PET…
computed tomography (CT), and 18 F-fluorodeoxyglucose positron emission tomography (FDG-PET…
18FDG uptake in oesophageal adenocarcinoma: linking biology and outcome
M Westerterp, GW Sloof, OS Hoekstra… - Journal of cancer …, 2008 - Springer
Purpose Variable uptake of 18 FDG has been noticed in positron emission tomography (PET)
studies of patients with oesophageal adenocarcinoma. The aim of the present study was to …
studies of patients with oesophageal adenocarcinoma. The aim of the present study was to …
Monitoring of response to pre-operative chemoradiation in combination with hyperthermia in oesophageal cancer by FDG-PET
M Westerterp, JMT Omloo, GW Sloof… - International journal …, 2006 - Taylor & Francis
Purpose: To evaluate the use of positron emission tomography using 18 F-fluorodeoxyglucose
(FDG-PET) to assess early response to pre-operative chemoradiation therapy in …
(FDG-PET) to assess early response to pre-operative chemoradiation therapy in …
Lymphatic drainage routes of the gastric cardia visualized by lymphoscintigraphy
HA Cense, GW Sloof, JM Klaase… - Journal of Nuclear …, 2004 - Soc Nuclear Med
This study was undertaken to assess the feasibility of lymphoscintigraphy of the gastric
cardia and to identify the incidence of paraesophageal lymphatic drainage, precluding total …
cardia and to identify the incidence of paraesophageal lymphatic drainage, precluding total …
Response monitoring of neoadjuvant therapy using CT, EUS, and FDG-PET
GW Sloof - Best Practice & Research Clinical Gastroenterology, 2006 - Elsevier
Neoadjuvant or adjuvant multimodality therapy in oesophageal cancer is introduced in an
effort to improve prognosis. However, in a substantial fraction of patients there is no response …
effort to improve prognosis. However, in a substantial fraction of patients there is no response …
In vivo prediction of response to antiestrogen treatment in estrogen receptor-positive breast cancer
…, AL Noorduyn, AG Janssen, GW Sloof - Journal of Nuclear …, 2004 - Soc Nuclear Med
In metastatic breast cancer, the estrogen receptor (ER) is a well-known prognostic factor
predictive of response to hormonal treatment in most, but not all, patients. Recently, a receptor-…
predictive of response to hormonal treatment in most, but not all, patients. Recently, a receptor-…
Estrogen Receptor Status in Primary Breast Cancer: Iodine 123–labeled cis-11β-Methoxy-17α-iodovinyl Estradiol Scintigraphy1
…, LA Noorduyn, AG Janssen, GW Sloof - Radiology, 2001 - pubs.rsna.org
PURPOSE: To determine the sensitivity of iodine 123 ( 123 I)–labeled cis-11β-methoxy-17α-iodovinyl
estradiol (Z-MIVE) scintigraphy for the detection of estrogen receptors in patients …
estradiol (Z-MIVE) scintigraphy for the detection of estrogen receptors in patients …